ICHR looks cheap. But this one does seem to have its cycles where everyone throws it away (like now). Hopefully they'll be buying back in the mid-high $20's after another stellar earnings report in a few weeks. Stock would still be very undervalued there imo
Noticed Stifel Nicholas raised their price target on ICHR from $44 to $48 this morning:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.